Lisondra, Clara E.

HRN: 28-99-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/12/2026
05/19/2026
IV
500mg
Q8
Amoebiasis Intestinal
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines